NEWS
Find a Professional: Explore Experts Across 197 Disciplines in 221 Countries!
Just Updated: Compare Your Institution (Live Data)
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025 (Updated Today)
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
Login
Register & Pricing
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
For Students
local_fire_department
Country Reports
person
Find a Professional
Hemant Kumar Vyas
Alkermes - Dublin / Ireland
Medical and Health Sciences / Immunology
AD Scientific Index ID: 4970612
Registration, Add Profile,
Premium Membership
Get Your Global Impact Certificate
Ranking &
Analysis
Job
Experiences
Education
Information
Published Books
Book Chapters
Articles
Presentations
Lessons
Projects
Co-Authors
Subject Leaders
Editorship, Referee &
Scientific Board
Patents /
Designs
Academic Grants
& Awards
Artistic
Activities
Certificate / Course
/ Trainings
Association &
Society Memberships
Contact, Office
& Social Media
person_outline
Hemant Kumar Vyas's MOST POPULAR ARTICLES
1-)
Recent advances in contraceptive vaccine development: a mini-review Human Reproduction 20 (12), 3271-3283, 2005
2-)
Defense-in-depth by mucosally administered anti-HIV dimeric IgA2 and systemic IgG1 mAbs: complete protection of rhesus monkeys from mucosal SHIV challenge Vaccine 33 (17), 2086-2095, 2015
3-)
Selective killing of leukemia and lymphoma cells ectopically expressing HCGβ by a conjugate of curcumin with an antibody against HCGβ subunit Oncology 76 (2), 101-111, 2009
4-)
Gonadotropin-releasing hormone/human chorionic gonadotropin β based recombinant antibodies and vaccines Journal of Reproductive immunology 83 (1-2), 158-163, 2009
5-)
Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV: outcome depends on IgG dose Retrovirology 11, 1-15, 2014
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept